{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:27:57Z","timestamp":1790285277499,"version":"4.1.0"},"reference-count":36,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anaesth Intensive Care"],"published-print":{"date-parts":[[2008,5]]},"abstract":"<jats:p>Advances in analysis of the RYR1 gene (which encodes the skeletal muscle ryanodine receptor) show that genetic examination is a useful adjunct to the in vitro contracture test in the diagnosis of malignant hyperthermia, as defects in RYR1 have been shown to be responsible for malignant hyperthermia susceptibility. DNA from 34 malignant hyperthermia susceptible individuals and four malignant hyperthermia equivocal subjects was examined using direct sequencing of \u2018hotspots\u2019 in the RYR1 gene to identify mutations associated with malignant hyperthermia. Seven different causative mutations (as defined by the European Malignant Hyperthermia Group) in nine malignant hyperthermia susceptible individuals were identified. In another six malignant hyperthermia susceptible individuals, five different published but as yet functionally uncharacterised mutations were identified. A further three as yet unpublished and functionally uncharacterised (novel) mutations were identified in three malignant hyperthermia susceptible samples. If the novel and previously published mutations prove to be functionally associated with calcium homeostasis, then this method of analysis achieved a mutation detection rate of 47%. Based on the number of relatives presenting to our unit in the study period, the muscle biopsy rate would have decreased by 25%. That we only identified a genetic defect in RYR1 in 47% of in vitro contracture test positive individuals suggests that there are other areas in RYR1 where pathogenic mutations may occur and that RYR1 may not be the sole gene associated with malignant hyperthermia. It may also reflect a less than 100% specificity of the in vitro contracture test.<\/jats:p>","DOI":"10.1177\/0310057x0803600311","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T04:16:37Z","timestamp":1547612197000},"page":"391-403","source":"Crossref","is-referenced-by-count":18,"title":["Identification of Genetic Mutations in Australian Malignant Hyperthermia Families Using Sequencing of Ryr1 Hotspots"],"prefix":"10.1177","volume":"36","author":[{"given":"R. L.","family":"Gillies","sequence":"first","affiliation":[{"name":"Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Parkville and Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, Victoria, Australia"},{"name":"Head of Malignant Hyperthermia Diagnostic Unit, Royal Melbourne Hospital."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. R.","family":"Bjorksten","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Parkville and Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, Victoria, Australia"},{"name":"Medical Scientist, Department of Anaesthesia and Pain Management."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Parkville and Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, Victoria, Australia"},{"name":"Department of Anatomical Pathology, Royal Perth Hospital, Perth, Western Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Du Sart","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Parkville and Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, Victoria, Australia"},{"name":"Molecular Genetics Laboratory, Victorian Clinical Genetics Services."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2008,5,1]]},"reference":[{"key":"bibr1-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/85.1.118"},{"key":"bibr2-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(87)90434-2"},{"key":"bibr3-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1038\/343559a0"},{"key":"bibr4-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1038\/343562a0"},{"key":"bibr5-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200405000-00008"},{"key":"bibr6-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/86.2.283"},{"key":"bibr7-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199404000-00008"},{"key":"bibr8-0310057X0803600311","unstructured":"A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group."},{"key":"bibr9-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-198910000-00015"},{"key":"bibr10-0310057X0803600311","unstructured":"University of California, Santa Cruz (UCSC) Genome Browser on Human Mar. 2006 Assembly. From http:\/\/genome.ucsc.edu\/cgi-bin\/hgTracks?org=human Accessed November 2007."},{"key":"bibr11-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1038\/ng0993-51"},{"key":"bibr12-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20231"},{"key":"bibr13-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20356"},{"key":"bibr14-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1016\/0888-7543(92)90042-Q"},{"key":"bibr15-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/3.3.471"},{"key":"bibr16-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/88.4.508"},{"key":"bibr17-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1086\/301748"},{"key":"bibr18-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/3.10.1855"},{"key":"bibr19-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/9.10.1515"},{"key":"bibr20-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1373\/49.5.761"},{"key":"bibr21-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/8.11.2055"},{"key":"bibr22-0310057X0803600311","unstructured":"University of California, Santa Cruz (UCSC) Vertebrate Multiz Alignment & PhastCons Conservation. From http:\/\/genome.ucsc.edu\/cgi-bin\/hgGateway?org=Human&db=hg18 Accessed November 2007."},{"key":"bibr23-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200211000-00007"},{"key":"bibr24-0310057X0803600311","unstructured":"European Malignant Hyperthermia Group - List of Causative Mutations compiled by T. Girard. From http:\/\/www.emhg.org\/index.php?option=com_ryr1&Itemid=66 Accessed November 2006."},{"key":"bibr25-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200503000-00007"},{"key":"bibr26-0310057X0803600311","doi-asserted-by":"crossref","unstructured":"XXIV Annual Meeting of the European Malignant Hyperthermia Group. Mainz, Germany. May 19-21, 2005 Report of scientific meeting. Anesthesiology 2005; 103 no. 6.","DOI":"10.1097\/00000542-200512010-00045"},{"key":"bibr27-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1016\/S0888-7543(05)80206-X"},{"key":"bibr28-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/6.6.953"},{"key":"bibr29-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1086\/515454"},{"key":"bibr30-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/3.6.969"},{"key":"bibr31-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1997.tb04820.x"},{"key":"bibr32-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.2000.01566.x"},{"key":"bibr33-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199703000-00014"},{"key":"bibr34-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1016\/S0143-4160(02)00138-0"},{"key":"bibr35-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.42.26332"},{"key":"bibr36-0310057X0803600311","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-6576.2002.460610.x"}],"container-title":["Anaesthesia and Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0310057X0803600311","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0310057X0803600311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:07:01Z","timestamp":1777367221000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0310057X0803600311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["10.1177\/0310057X0803600311"],"URL":"https:\/\/doi.org\/10.1177\/0310057x0803600311","relation":{},"ISSN":["0310-057X","1448-0271"],"issn-type":[{"value":"0310-057X","type":"print"},{"value":"1448-0271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}